Biblio
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives. Front Biosci (Landmark Ed). 2019;24:1284-1315.
. CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results. Leuk Res. 2019;83:106169.
. Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. Blood Adv. 2022;6(13):3875-3878.